Follow-The-Filings

Security · featured owners

EVH Evolent Health Inc.

Consumer Discretionary CL A Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 9.2%
  • $30M
  • 2 exits

EVH (Evolent Health Inc.) is held in 1 featured 13F book as of 2026 Q2. Glenn Welling - Engaged Capital is the largest tracked holder by portfolio weight (9.2%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 9.2% (Glenn Welling - Engaged Capital) · not free-float ownership

  1. Glenn Welling 9.2%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Glenn Welling - Engaged Capital 2026 Q2 9.2% Hold 5,563,912 $30M History
Lee Ainslie - Maverick Capital exited 2026 Q2 Last 2026 Q1 0.07% Exit −0.07% 2,572,763 $6M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 14,000 $32K History

1 current · 2 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 18 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 5.02,7.01 Filing Doc
10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,2.03,3.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 8 rows shown

Filed Form Detail Links
4 Period Aug 26, 2026 Filing Doc
4 Period Jul 1, 2026 · 4 forms Filing Doc
4 Period Jun 4, 2026 · 9 forms Filing Doc
4 Period Mar 2, 2026 Filing Doc
4 Period Mar 1, 2026 · 4 forms Filing Doc
4 Period Jan 2, 2026 Filing Doc
4 Period Jan 2, 2026 Filing Doc
4 Period Nov 18, 2025 Filing Doc

Updated 17 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.96B $2.55B $1.88B
Gross profit * $460.47M $367.35M $399.88M
Gross margin * 23.4% 14.4% 21.3%
Net income -$113.04M -$61.62M -$534.51M
Net margin * -5.8% -2.4% -28.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $683.67M $607.12M $506.37M
Total non-current assets * $2B $1.94B $1.39B
Total assets $2.68B $2.54B $1.9B
Total current liabilities $674.24M $715.5M $385.26M
Total non-current liabilities * $0.76B $0.637B $1.1B
Total equity $1.07B $1B $0.415B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $142.58M $18.76M $38.84M
Cash from investing -$415.54M -$62.93M -$0.233M
Cash from financing $281.34M -$0.565M -$35.92M
Net change in cash $8.3M -$44.96M $2.2M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders